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Abstract: Uncaging of several neuroactive amino acids, namely β-alanine, tyrosine, 3,4-
dihydroxyphenylalanine (DOPA) and glutamic acid from the corresponding 5,6-benzocoumarinyl 
conjugates was carried out by irradiation at different wavelengths and in different solvent systems. 
The release of the various amino acids was faster in ACN/HEPES buffer mixtures and for the 
tyrosine conjugate, an increase in the photolysis reaction rates and the quantitative uncaging of the 
amino acid was associated with increasing water content in the solvent mixture. 
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1. Introduction 
 
Coumarins are structural units present in many natural compounds and a large number of their 
natural and synthetic derivatives exhibit diverse biological and pharmacological activities, but more 
recently they have gained recognition for their application as photocleavable protecting groups for 
the caging of biomolecules. They have been used in cell biology and biophysical studies with a range 
of chemical functionalities such as alcohols,
1
 amines,
2
 phosphates,
3
 carboxylic acids,
4
 aldehydes and 
ketones.
5
 A fused derivative of coumarin, 5,6-benzocoumarin and its derivatives have also been 
reported in photocleavage studies,
6-8
 and their electronic properties along with their photophysical 
characteristics make them promising for biological applications.
9,10
  
Photo-uncaging produces rapid, sequential release of biomolecules for finely tuned stimulation of 
biological events, so light-activable groups can be used as a powerful tool in the spatio-temporal 
controlled release of selected bioactive molecules from inactive (caged) forms by phototrigerring.
11
 
Important caged biomolecules include neurotransmitters, nucleotides, peptides, proteins, DNA and 
RNA.
12
 
Having in mind these facts and as a continuation of our work related with the investigation of 
alternative heterocyclic photolabile protecting groups,
6-8,13-16
 we now report the evaluation of the 
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release under irradiation of neuroactive amino acids β-alanine, tyrosine, 3,4-dihydroxyphenylalanine 
and glutamic acid from the corresponding 5,6-benzocoumarinyl ester conjugates. Photo-uncaging 
studies were carried out at 254, 300, 350 and 419 nm in mixtures of aqueous HEPES buffer and 
organic solvents in different ratios and cleavage kinetic data obtained by HPLC/UV monitoring. 
 
 
2. Results and discussion 
 
5,6-Benzocoumarin - neuroactive amino acid conjugates 2a-e were obtained by cleavage of N-
benzyloxycarbonyl (Z) or N-tert-butyloxycarbonyl (Boc) groups under usual chemical deprotection 
conditions from the corresponding precursors 1a-e with β-alanine, tyrosine, 3,4-
dihydroxyphenylalanine and glutamic acid (Scheme 1). The 5,6-benzocoumarinyl moiety will be 
designated in this report by a three-letter code (Bba) for simplicity of naming the various fluorescent 
conjugates, as indicated in Table 1. All compounds synthesized were fully characterized by high 
resolution mass spectrometry, IR, 
1
H and 
13
C NMR spectroscopy. The IR spectra of conjugates 2a-e 
showed bands due to stretching vibrations of the different carbonyl groups present at the 
benzocoumarin-amino acid conjugates from 1625 to 1752 cm
-1
. 
1
H NMR spectra showed signals of 
the amino acid residues, such as the α-CH (δ 3.80 to 4.35 ppm) and the α-, - and -CH2 (δ 1.99 to 
3.01 ppm), in addition to the benzocoumarin methylene group (δ 5.09 to 6.04 ppm). Also the 
characteristic H-2 of the 5,6-benzocoumarin ring was present (δ 6.60-6.74 ppm). As it was expected, 
the deprotection procedures did not affect the integrity of the ester linkage between the amino acid 
and the benzocoumarin, as confirmed by 
13
C NMR spectra signals of the carbonyl group, at δ 
168.69-177.67 ppm.  
 
In order to obtain the parameters necessary for the monitoring of the photolysis reaction, as well as 
the fluorescence properties, the UV/vis characterization was carried out in absolute ethanol and 
different solvent mixtures. The absorption and emission spectra of conjugates 2a-e in degassed 
solutions in absolute ethanol, MeOH/HEPES buffer (80:20) and ACN/HEPES buffer (80:20) were 
measured (Table 1, Figure 1). By comparison of the absorption maxima, no significant differences 
were observed in these solvents (between 341 and 346 nm), although for the water containing solvent 
systems, there was a slight bathochromic shift (4 to 16 nm) in the wavelength of maximum emission, 
relative to the data collected in absolute ethanol. The Stokes’ shift was between 113 and 130 nm, 
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which is an advantageous property in fluorescence techniques as it will minimize self-quenching 
phenomena. 
Relative fluorescence quantum yields were determined using 9,10-diphenylanthracene in ethanol as 
standard,
17
 and it was found that all conjugates were highly emissive in ethanol (ΦF from 0.75 to 
0.86), with the exception of the lower value obtained for the DOPA conjugate 2c (ΦF = 0.29). The 
same trend was previously reported by us for the precursor conjugates 1a-e bearing a N-
benzyloxycarbonyl protecting group. High ΦF values were also obtained for 2a-e in MeOH/HEPES 
buffer (80:20), with that of 2c increasing to 0.48, whereas in ACN/HEPES buffer (80:20) the 
quantum yield was lower for all conjugates.  
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Table 1.  
 
 
 
 
Compound 
Yield  
(%) 
EtOH MeOH/HEPES (80:20) ACN/HEPES (80:20) 
λabs
a
 log ε λem
a
 ΦF λ
a
 λabs
a
 log ε λem
a
 ΦF λ
a
 λabs
a
 log ε λem
a
 ΦF λ
a
 
2a H-β-Ala-OBba 98 344 4.02 465 0.86 121 344 3.94 473 0.83 129 342 3.94 470 0.50 128 
2b H-Tyr-OBba 76 344 3.98 460 0.81 116 344 3.97 474 0.70 130 341 3.94 464 0.26 123 
2c H-DOPA-OBba 23 345 3.92 459 0.29 114 343 3.76 473 0.48 130 342 4.03 467 0.09 125 
2d H-Glu(OMe)-OBba 95 346 3.93 460 0.75 114 344 4.27 473 0.75 129 342 4.07 469 0.47 127 
2e H-Glu(OBba)-OMe 51 345 3.92 458 0.84 113 344 3.76 474 0.79 130 342 4.06 468 0.47 126 
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Figure 1. 
 
The sensitivity of the 5,6-benzocoumarin - neuroactive amino acid conjugates towards UV/vis 
irradiation was evaluated by exposing solutions of the mentioned compounds to radiation at 254, 
300, 350 and 419 nm, and monitorised by HPLC/UV. Given our previous results with other 
heterocyclic conjugates for photolysis in different solvent systems with varying aqueous content,
18
 
solutions of 2a-e were prepared in MeOH/HEPES buffer (80:20). Peak areas (A) of conjugates 2a-e 
revealed a gradual decrease with the irradiation time until less than 5% of the initial area was 
detected (Table 2). The plots of ln A versus irradiation time showed a linear correlation suggesting a 
first order reaction, obtained by the linear least squares methodology for a straight line. Rate 
constants were calculated and are presented in Table 2.  
In MeOH/HEPES buffer (80:20), it was found that the irradiation times were long at the tested 
wavelengths. Nonetheless, for all conjugates the best results were obtained at 254 nm with the 
cleavage being more than 2 times faster than at 300 or 350 nm. For each set of results at a particular 
wavelength, the structure of the neuroactive amino acid was not significantly influential on the 
reaction rates, although some tendencies were visible: photolysis of the glutamic acid conjugates 
bearing the 5,6-benzocoumarinyl photolabile group at the main chain, 2d, or at the side chain, 2e, 
revealed that cleavage of the ester bond at the side chain was faster for all wavelengths of irradiation, 
while the DOPA conjugate 2c photolysis was slower than that of tyrosine conjugate 2b, probably 
indicating a detrimental effect of the extra hydroxyl group.  
Photolysis was also carried out with mixtures of methanol with water content higher than 20%, in an 
attempt to improve the photoreaction rates. For tyrosine conjugate 2b in a 50:50 mixture at 300 nm, 
it was possible to achieve the quantitative release of tyrosine within 3.2 h, which represents a 
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significant decrease in the irradiation time (ca. 9 times). For the other conjugates, the reaction rates 
were not improved with the increase in the water content, when compared to the results obtained in a 
80:20 mixture. 
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Table 2.  
 
 
Compound 
MeOH/HEPES (80:20) ACN/HEPES (80:20) 
254 nm 300 nm 350 nm 254 nm 300 nm 350 nm 
tirr k Φphot tirr k Φphot tirr k Φphot tirr k Φphot tirr k Φphot tirr k Φphot 
2a H-β-Ala-OBba 8.9 0.57 0.019 21.0 0.24 0.015 29.5 0.17 0.003 5.1 0.98 0.023 4.1 1.25 0.015 5.0 1.05 0.019 
2b H-Tyr-OBba 13.6 0.35 0.011 29.5 0.16 0.007 27.8 0.13 0.003 2.6 1.89 0.039 1.3 3.76 0.034 3.4 1.55 0.032 
2c H-DOPA-OBba 9.2 0.37 0.020 27.9 0.17 0.008 19.3 0.18 0.008 5.2 0.98 0.014 14.8 0.34 0.002 10.3 0.49 0.008 
2d H-Glu(OMe)-OBba 14.3 0.55 0.005 31.5 0.18 0.004 38.3 0.26 0.001 4.6 1.10 0.021 6.2 0.80 0.012 6.6 0.78 0.011 
2e H-Glu(OBba)-OMe 7.5 0.65 0.026 20.1 0.25 0.013 33.1 0.15 0.005 3.8 1.39 0.019 6.5 0.76 0.006 4.6 1.14 0.015 
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Taking into consideration the above mentioned findings, it was decided to test an aprotic organic 
solvent, namely acetonitrile, which is also suitable for photocleavage studies.
19
 Therefore, solutions 
of conjugates 2a-e in ACN/HEPES buffer (80:20) were irradiated in the same conditions. As can be 
seen from the data collected in Table 2, the resulting irradiation times were significantly decreased, 
especially at 300 and 350 nm, when compared to those obtained in MeOH/HEPES buffer (80:20). 
Concerning the influence of the wavelength of irradiation on the rate of the photocleavage reactions 
of conjugates 2a-e in ACN/HEPES buffer (80:20) solution, it was found that the shorter irradiation 
times were observed at 300 nm for conjugates 2a and 2b and at 254 nm for conjugates 2c-e. By 
comparison of the results at 300 and 350 nm, it was noticeable that the release of β-alanine 3a, 
tyrosine 3b and glutamic acid 3d was faster at 300 nm, contrary to the release of DOPA 3c and 
glutamic acid 3e, with shorter irradiation times at 350 nm. No significant difference in the release of 
glutamic acid methyl ester (3d and 3e) was seen in the cleavage of the conjugate’s ester bond at its 
main (2d) or side chain (2e) at 300 nm (Figure 2). 
Furthermore, considering the influence of the structure of the neurotransmitter on the photocleavage 
rates, it was possible to see that the DOPA conjugate 2c had the largest irradiation times for all 
wavelengths. In contrast, the irradiation times for the cleavage of tyrosine conjugate 2b were always 
shorter, being the best result at 300 nm (1.3 h). In this solvent system, cleavage at 419 nm was also 
attempted resulting in a long, unpractical irradiation time. Also, photolysis in mixtures of acetonitrile 
with higher water content were tested, the best results being obtained for the tyrosine conjugate 2b in 
50:50 (1.0 h), 20:80 (0.7 h) and 10:90 (0.6 h) ACN/HEPES buffer mixtures. For this conjugate, there 
was a visible increase in the reaction rate with the increasing water content. 
The photochemical quantum yields of the photocleavage process in MeOH/HEPES buffer (80:20) 
and ACN/HEPES buffer (80:20) solutions of compounds 2a-e were also calculated based on half-
lives (t1/2), molar absorptivities () and the incident photon flux (I0), determined by potassium 
ferrioxalate actinometry
20,21
 (at 254, 300, 350 and 419 nm, 1.221017, 2.541017, 2.631017 and 
2.611017 photons s-1 cm-2, respectively) (Table 2). 
Taking into account the determined photochemical quantum yields, it was found that the 
photocleavage process was not as efficient as desirable, probably due to the dissipation of part of the 
absorbed energy via fluorescence pathways that compete with the photocleavage reaction, as well as 
the type of reactor used (open chamber reactor) and the low power of the lamps (14–35 W). 
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Figure 2.  
 
 
3. Conclusions 
 
The release of the various neuroactive amino acids was achieved by irradiation of the corresponding 
5,6-benzocoumarinyl ester conjugates at different wavelengths and in diverse solvent systems. 
Photolysis was faster in ACN/HEPES buffer mixtures and for the tyrosine conjugate, an increase in 
the photolysis reaction rates and the quantitative uncaging of the amino acid was associated with 
increasing water content in the solvent mixture. 
 
 
4. Experimental Section 
 
4.1. General 
All melting points were measured on a Stuart SMP3 melting point apparatus and are uncorrected. 
TLC analyses were carried out on 0.25 mm thick precoated silica plates (Merck Fertigplatten 
Kieselgel 60F254) and spots were visualised under UV light. Chromatography on silica gel was 
carried out on Merck Kieselgel (230-240 mesh).  IR spectra were determined on a BOMEM MB 104 
spectrophotometer. UV/vis absorption spectra (200 – 700 nm) were obtained using a Shimadzu 
UV/2501PC spectrophotometer. NMR spectra were obtained on a Varian Unity Plus Spectrometer at 
an operating frequency of 300 MHz for 
1
H NMR and 75.4 MHz for 
13
C NMR or a Bruker Avance III 
400 at an operating frequency of 400 MHz for 
1
H NMR and 100.6 MHz for 
13
C NMR using the 
solvent peak as internal reference at 25 ºC. All chemical shifts are given in ppm using δ Me4Si = 0 
ppm as reference and J values are given in Hz. Assignments were made by comparison of chemical 
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shifts, peak multiplicities and J values and were supported by spin decoupling-double resonance and 
bidimensional heteronuclear correlation techniques.  High resolution mass spectrometry analyses 
were performed at the “C.A.C.T.I. - Unidad de Espectrometria de Masas”, at University of Vigo, 
Spain.  
 
4.2. Synthesis procedures for conjugates 1b and 1c 
4.2.1. Synthesis of N-(tert-butyloxycarbonyl)-L-tyrosine (9-methoxy-(5,6)-benzocoumarin-1-yl) 
methyl ester, Boc-Tyr-OBba 1b. 1-Choromethyl-9-methoxy-(5,6)-benzocoumarin, Bba-Cl (0.083 
g, 0.302 mmol) was dissolved in dry DMF (3 mL), potassium fluoride (0.053 g, 0.907 mmol) and 
Boc-Tyr-OH (0.085 g, 0.302 mmol) were added. The reaction mixture was stirred at room 
temperature for 3 days. The solvent was removed by rotary evaporation under reduced pressure and 
the crude residue was purified by column chromatography in silica gel using 
dichloromethane/methanol 100:1 as eluent, to give compound 1b as a yellow solid (0.118 g, 96 %). 
Mp = 96.6 – 98.2 ºC. 1H NMR (DMSO-d6): δ = 1.32  (s, 9 H, C(CH3)3), 2.81 – 2.89 (m, 2 H, β-CH2), 
3.94 (s, 3 H, OCH3), 4.22 – 4.25 (m, 1 H, α-CH), 5.79 (d, J 6.0 Hz, 2 H, CH2 Bba), 6.62 (d, J 8.4 Hz, 
2 H, H-3 and H-5 Tyr), 6.63 (s, 1 H, H-2), 7.01 (d, J 8.4 Hz, 2 H, H-2 and H-6 Tyr),  7.29 (dd, J 9.2 
and 2.4 Hz, 1 H, H-8),7.40 (d, J 8.8 Hz, 1 H, H-5), 7.46 (d, J 7.6 Hz, 1 H, α-NH), 7.50 (d, J 1.6 Hz, 1 
H, H-10), 8.00 (d, J 8.8 Hz, 1 H, H-7), 8.14 (d, J 8.8 Hz, 1 H, H-6).
13
C NMR (DMSO-d6): δ = 28.05 
(C(CH3)3), 35.45 (β-CH2), 55.30 (OCH3), 55.82 (α-C), 64.41 (CH2 Bba), 78.45 (C(CH3)3), 105.96 
(C-10), 111.53 (C-4b), 112.24 (C-2), 114.79 (C-5), 114.95 (C-3 and C-5 Tyr), 116.83 (C-8), 125.97 
(C-6a), 127.30 (C-1 Tyr), 129.98 (C-2 and C-6 Tyr), 130.16 (C-6b), 131.21 (C-7), 133.94 (C-6), 
151.51 (C-1), 154.89 (C-4a), 155.49 (CONH), 155.96 (C-4 Tyr), 159.15 (C-9 and C-3), 171.73 
(CO2CH2). IR (KBr 1%, cm
-1
): υ = 3383, 2977, 2934, 1714, 1625, 1517, 1446, 1366, 1272, 1233, 
1186, 1105, 1062, 1023, 989, 944, 838, 729. HRMS (ESI): calcd for C29H30NO8 [M
+
+H]: 520.19720; 
found: 520.19745. 
 
4.2.2. Synthesis of N-(tert-butyloxycarbonyl)-3,4-dihydroxy-L-phenylalanine (9-methoxy-(5,6)-
benzocoumarin-1-yl) methyl ester, Boc-DOPA-OBba 1c. Starting from Bba-Cl  (0.112 g, 0.41 
mmol), DMF (3 mL), potassium fluoride (0.071 g, 1.22 mmol) and Boc-BOPA-OH (0.121 g, 0.41 
mmol), following the same procedure as described  for 1b, compound 1c was obtained as a yellow 
solid (0.166 g, 76 %). Mp = 113.1 – 114.7 ºC. 1H NMR (DMSO-d6): δ = 1.32 (s, 9 H, C(CH3)3), 2.48 
– 2.50 (m, 2 H, β-CH2), 3.95 (s, 3 H, OCH3), 4.18 – 4.23 (m, 1 H, α-CH), 5.80 (d, J 3.6 Hz, 2 H, 
CH2 Bba), 6.46 (dd, J 8.0 and 2.0 Hz, 1 H, H-6 DOPA), 6.60 (d, J 8.8 Hz, 1 H, H-5 DOPA), 6.61 (d, 
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J 1.6 Hz, 1 H, H-2 DOPA), 6.65 (s, 1 H, H-2), 7.30 (dd, J 9.2 and 2.4 Hz, 1 H, H-8), 7.41 (d, J 8.8 
Hz, 1 H, H-5), 7.42 (d, J 8.0 Hz, 1 H, α-NH), 7.50 (d, J 1.2 Hz, 1 H, H-10), 8.01 (d, J 8.8 Hz, 1 H, H-
7), 8.15 (d, J 8.8 Hz, 1 H, H-6), 8.68 (s, 1 H, OH), 8.71 (s, 1 H, OH).
 13
C NMR (DMSO-d6): δ = 
28.06 (C(CH3)3), 35.66 (β-CH2), 55.31 (OCH3), 55.88 (α-C), 64.41 (CH2 Bba), 78.47 (C(CH3)3), 
105.95 (C-10), 111.54 (C-4b), 112.16 (C-2), 114.80 (C-5), 115.29 (C-5 DOPA), 116.38 (C-2 
DOPA), 116.85 (C-8), 119.74 (C-6 DOPA), 125.97 (C-6a), 128.02 (C-1 DOPA), 130.17 (C-6b), 
131.22 (C-7), 133.95 (C-6), 143.89 (C-4 DOPA), 144.91 (C-3 DOPA),  151.58 (C-1), 154.90 (C-4a), 
155.50 (CONH), 159.16 (C-3 and C-9), 171.76 (CO2CH2). IR (KBr 1%, cm
-1
): υ = 3378, 2977, 2935, 
1712, 1625, 1552, 1519, 1445, 1367, 1282, 1233, 1162, 1115, 1062, 1022, 950, 840, 821, 804, 730. 
HRMS (ESI): calcd for C29H30NO9 [M
+
+H]: 536.19210; found: 536.19221. 
 
 
4.3. Synthesis procedures for conjugates 2a-e 
4.3.1. Synthesis of β-alanine (9-methoxy-(5,6)-benzocoumarin-1-yl) methyl ester hydrobromide, 
HBr.H-β-Ala-OBba 2a. A 45% solution of hydrobromic acid in acetic acid (36 μL), and acetic acid 
(0.5 mL) were added to N-(benzyloxycarbonyl)-β-alanine-(9-methoxy-(5,6)-benzocoumarin-1-
yl)methyl ester, Z-β-Ala-OBba 1a7 (0.040 g, 0.087 mmol) with stirring, at room temperature. The 
reaction mixture was maintained in these conditions for four days, and the process was followed by 
TLC (dichloromethane/methanol 50:1). When the reaction was completed, cold diethyl ether was 
added (1 mL), and the precipitate filtered off and washed with the same solvent to give 2a as a 
yellow solid (0.035 g, 98 %). Mp = 189.0 – 190.8 ºC. 1H NMR (DMSO-d6): δ = 2.60 – 2.70 (m, 2 H, 
CH2), 3.01 (t, J 7.2 Hz, 2 H, CH2), 3.94 (s, 3 H, OCH3), 5.13 (d, J 0.8 Hz, 2 H, CH2 Bba), 6.72 (s, 1 
H, H-2), 7.27 (dd, J 8.8 and 2.4 Hz, 1 H, H-8), 7.38 (d, J 8.8 Hz, 1 H, H-5), 7.74 (d, J 2.4 Hz, 1 H, 
H-10), 7.98 (d, J 9.2 Hz, 1 H, H-7), 8.10 (d, J 8.8 Hz, 1 H, H-6). 
13
C NMR (DMSO-d6): δ = 31.70 
(CH2), 34.87 (CH2), 51.71 (OCH3), 62.54 (CH2 Bba), 106.49 (C-10), 111.77 (C-2), 112.25 (C-4b), 
114.84 (C-5), 116.69 (C-8), 125.95 (C-6a), 130.52 (C-6b), 130.98 (C-7), 133.51 (C-6), 154.78 (C-
4a), 158.19 (C-1), 159.04 (C-9), 159.81 (C-3), 170.85 (CO2CH2). IR (KBr 1%, cm
-1
): υ = 3378, 
3288, 3218, 3089, 2965, 2260, 1717, 1683, 1427, 1554, 1519, 1427, 1375, 1365, 1337, 1279, 1203, 
1131, 1068, 1050, 1025, 987, 857, 722. HRMS (ESI): calcd for C18H18NO5 [M
+
+H]: 328.11795; 
found: 328.11723. 
 
4.3.2. Synthesis of L-tyrosine (9-methoxy-(5,6)-benzocoumarin-1-yl) methyl ester, H-Tyr-OBba 
2b. To a solution of Boc-Tyr-OBba 1b (0.062 g, 0.119 mmol) in dichloromethane (2 mL), 
trifluoroacetic acid (1 mL) was added and the reaction mixture was stirred at room temperature for 
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24 hours. The process was followed by TLC (dichloromethane/methanol 50:1). After evaporation, 
aqueous buffer solution (pH 8) was added (5 mL) to the resulting residue followed by extraction with 
ethyl acetate. Compound 2b was obtained as a yellow solid (0.046 g, 76 %). Mp = 146.8 – 147.9 ºC. 
1
H NMR (DMSO-d6): δ = 2.74 – 2.90 (m, 2 H, β-CH2), 3.80 – 3.90 (m, 1 H, α-CH), 3.94 (s, 3 H, 
OCH3), 5.70 – 5.85 (m, 2 H, CH2 Bba), 6.53 (broad s, 2 H, NH2), 6.60 (s, 1 H, H-2), 6.61 (d, J 8.8 
Hz, 2 H, H-3 and H-5 Tyr), 6.96 (d, J 8.8 Hz, 2 H, H-2 and H-6 Tyr), 7.30 (dd, J 9.0 and 2.4 Hz, 1 H, 
H-8), 7.41 (d, J 9.2 Hz, 1 H, H-5), 7.52 (d, J 2.0 Hz, 1 H, H-10), 8.02 (d, J 9.2 Hz, 1 H, H-7), 8.15 
(d, J 8.8 Hz, 1 H, H-6), 9.21 (s, 1 H, OH). 
13
C NMR (DMSO-d6): δ = 38.62 (β-CH2), 55.32 (OCH3), 
55.40 (α-C), 64.35 (CH2 Bba), 106.05 (C-10), 111.80 (C-4b), 112.52 (C-2), 114.86 (C-5), 115.06 (C-
3 and C-5 Tyr), 116.81 (C-8), 126.01 (C-6a), 126.63 (C-1 Tyr), 130.06 (C-6b), 130.15 (C-2 and C-6 
Tyr), 131.29 (C-7), 134.02 (C-6), 151.38 (C-1), 154.94 (C-4a), 156.11 (C-4 Tyr), 159.16 (C-9), 
159.22 (C-3), 172.90 (CO2CH2). IR (KBr 1%, cm
-1
): υ = 3365, 3225, 1712, 1625, 1552, 1517, 1445, 
1364, 1233, 1200, 1178, 1140, 1062, 1023, 949, 839, 722. HRMS (ESI): calcd for C24H22NO6 
[M
+
+H]: 420.14416; found: 420.14481. 
 
4.3.3. Synthesis of 3,4-dihydroxy-L-phenylalanine (9-methoxy-(5,6)-benzocoumarin-1-yl) 
methyl ester, H-DOPA-OBba 2c. Starting from Boc-DOPA-OBba 1c (0.166 g, 0.31 mmol), 
dichloromethane (0.5 mL) and trifluoroacetic acid (0.5 mL), following the same procedure as 
described for compound 2b, compound 2c was obtained as a yellow solid (0.041 g, 31%). Mp = 
277.2 – 278.5 ºC. 1H NMR (DMSO-d6): δ = 2.83-2.86 (m, 2 H, β-CH2), 3.92 (s, 3 H, OCH3), 3.98 – 
4.02 (m, 1 H, α-CH), 5.11 (s, 2 H, CH2 Bba), 6.41 (dd, J 8.0 and 2.0 Hz, 1 H, H-6 DOPA), 6.54 (d, J 
2.0 Hz, 1 H, H-2 DOPA), 6.64 (d, J 8.0 Hz, 1 H, H-5 DOPA), 6.70 (s, 1 H, H-2), 7.25 (d, J 8.8 and 
2.4 Hz, 1 H, H-8), 7.37 (d, J 8.8 Hz, 1 H, H-5), 7.72 (d, J 2.4 Hz, 1 H, H-10), 7.92 (d, J 8.8 Hz, 1 H, 
H-7), 8.08 (d, J 8.8 Hz, 1 H, H-6), 8.93 (broad s, 2 H, 2 × OH). 
13
C NMR (DMSO-d6): δ = 36.53 (β-
CH2), 54.14 (α-C), 55.51 (OCH3), 62.79 (CH2 Bba), 106.71 (C-10), 112.00 (C-2), 112.49 (C-4b), 
115.08 (C-5), 115.89 (C-5 DOPA), 116.79 (C-2 DOPA), 116.94 (C-8), 120.40 (C-6 DOPA), 125.68 
(C-1 DOPA), 126.19 (C-6a), 130.74 (C-6b), 131.28 (C-7), 133.84 (C-6), 144.71 (C-4 DOPA), 
145.44 (C-3 DOPA), 155.01 (C-4a), 158.45 (C-1), 159.30 (C-9), 160.25 (C-3), 170.85 (CO2CH2). IR 
(KBr 1%, cm
-1
): υ = 3220, 2260, 1752, 1709, 1625, 1552, 1492, 1446, 1232, 1197, 1140, 1062, 1025, 
956, 839, 801, 723. HRMS (ESI): calcd for C24H22NO7 [M
+
+H]: 436.13908; found: 436.13901. 
 
4.3.4. Synthesis of 2-amino-5-methyl-1-(9-methoxy-(5,6)-benzocoumarin-1-yl)methyl 
pentanedioate hydrobromide, HBr.H-Glu(OMe)-OBba 2d. Starting from Z-Glu(OMe)-OBba 1d 
(0.020 g, 0.038 mmol),
7 
45% solution of hydrobromic acid in acetic acid (27 μL), and acetic acid (0.4 
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mL), following the same procedure as described for 2a, compound 2d was obtained as a yellow solid 
(0.017 g, 95 %). Mp = 167.0-168.3 ºC. 
1
H NMR (DMSO-d6): δ = 1.99 – 2.18 (m, 2 H, CH2), 2.45 – 
2.61 (m, 2 H, CH2), 3.56 (s, 3 H, OCH3 Glu), 3.95 (s, 3 H, OCH3), 4.32 – 4.35 (m, 1 H, α-CH), 5.90-
6.04 (m, 2 H, CH2 Bba), 6.74 (s, 1 H, H-2), 7.33 (dd, J 8.8 and 2. Hz, 1 H, H-8), 7.42 (d, J 8.8 Hz, 1 
H, H-5), 7.49 (d, J 2.0 Hz, 1 H, H-10), 8.04 (d, J 9.2 Hz, 1 H, H-7), 8.17 (d, J 8.8 Hz, 1 H, H-6). 
13
C 
NMR (DMSO-d6): δ = 25.25 (CH2), 28.70 (CH2), 51.32 (α-C), 51.56 (OCH3 Glu), 55.37 (OCH3), 
65.47 (CH2 Bba), 106.30 (C-10), 111.42 (C-4b), 111.89 (C-2), 114.87 (C-5), 116.67 (C-8), 126.05 
(C-6a), 130.08 (C-6b), 131.41 (C-7), 134.16 (C-6), 151.11 (C-1), 154.94 (C-4a), 159.22 (C-9), 
159.31 (C-3), 168.69 (CO2CH2), 172.17 (CO2CH3). IR (KBr 1%, cm
-1
): υ = 3395, 3222, 2962, 1712, 
1687, 1626, 1552, 1520, 1444, 1238, 1203, 1139, 1089, 1039, 1018, 839, 801, 723. HRMS (ESI): 
calcd for C21H22NO7 [M
+ 
+H]: 400.13908; found: 400.13889. 
 
4.3.5. Synthesis of 4-amino-5-methyl-1-(9-methoxy-(5,6)-benzocoumarin-1-yl)methyl 
pentanedioate hydrobromide, HBr.H-Glu(OBba)-OMe 2e. Starting from Z-Glu(OBba)-OMe 1e 
(0.174 g, 0.362 mmol),
7 
45% solution of hydrobromic acid in acetic acid (63 μL), and acetic acid (1 
mL), following the same procedure as described for 2a (reaction time: two days), compound 2e was 
obtained as a yellow solid (0.088 g, 51 %). Mp = 224.0-225.2 ºC. 
1
H NMR (DMSO-d6): δ = 1.90 – 
2.0 (m, 1 H, β-CH2 Glu), 2.05 – 2.15 (m, 2 H, -CH2 Glu), 2.25 – 2.35 (m, 1 H, β-CH2 Glu), 3.64 (s, 
3 H, OCH3 Glu), 3.91 (s, 3 H, OCH3), 4.15 – 4.20 (m, 1 H, α-CH), 5.09 (s, 2 H, CH2 Bba), 6.69 (s, 1 
H, H-2), 7.24 (dd, J 9.0 and 2.0 Hz, 1 H, H-8), 7.35 (d, J 9.2 Hz, 1 H, H-5), 7.69 (d, J 2.0 Hz, 1 H, 
H-10), 7.95 (d, J 8.8 Hz, 1 H, H-7), 8.08 (d, J 9.2 Hz, 1 H, H-6). 
13
C NMR (DMSO-d6): δ = 24.67 (β-
CH2), 29.87 (-CH2), 52.34 (OCH3 Glu), 54.96 (α-C), 55.53 (OCH3), 62.75 (CH2 Bba), 106.69 (C-
10), 111.96 (C-2), 112.46 (C-4b), 115.06 (C-5), 116.92 (C-8), 126.18 (C-6a), 130.72 (C-6b), 131.28 
(C-7), 133.83 (C-6), 154.98 (C-4a), 158.46 (C-1), 159.28 (C-9), 160.24 (C-3), 173.60 (CO2CH3), 
177.67 (CO2CH2). IR (KBr 1%, cm
–1
): ν = 3354, 2982, 1693, 1627, 1590, 1548, 1524, 1440, 1422, 
1384, 1351, 1308, 1240, 1216, 1191, 1177, 1094. HRMS (ESI): calcd for C21H22NO7 [M
+
+H]: 
400.13908; found: 400.13870. 
 
4.4. Photolysis general 
Photolyses were carried out using a Rayonet RPR-100 chamber reactor equipped with 10 lamps of 
254, 300, 350 and 419 ± 10 nm. HPLC analyses were performed using a Licrospher 100 RP18 (5 
μm) column in a JASCO HPLC system composed by a PU-2080 pump and a UV-2070 detector with 
ChromNav software. 
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4.4.1. General photolysis procedure 
A 1  10-4 M solution of conjugates 2a-e (5 mL) in HEPES buffer with methanol or acetonitrile, in 
varying proportions, was placed in a quartz tube and irradiated in the reactor at the desired 
wavelength. HEPES buffer solution was prepared in distilled water with HEPES (4-(2-
hydroxyethyl)-1-piperazine ethanesulfonic acid) (10 mM), NaCl (120 mM), KCl (3 mM), CaCl2 (1 
mM) and MgCl2 (1mM) and pH adjusted to 7.2. Aliquots of 100 µL were taken at regular intervals 
and analysed by RP-HPLC. The eluent was acetonitrile/water, 3:1, at a flow rate of 0.8 mL/min, for 
all compounds (retention time at about 3.0 min), previously filtered through a Millipore, type HN 
0.45 µm filter and degassed by ultra-sound for 30 min. The chromatograms were traced by detecting 
UV absorption at the wavelength of maximum absorption for each conjugate. 
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CAPTIONS 
 
 
Scheme 1. Synthesis of conjugates 2a-e and photo-release of neuroactive amino acids 3a-e. Reagents 
and conditions: a) 45% hydrobromic acid/acetic acid, rt; b) trifluoroacetic acid/DCM (1:2), rt; c) hν, 
MeOH/HEPES buffer or ACN/HEPES buffer in different proportions. 
 
 
Table 1. Yields, UV/vis absorption and fluorescence data for neuroactive amino acid conjugates 2a-
e in absolute ethanol, MeOH/HEPES buffer (80:20) and ACN/HEPES buffer (80:20) solution. 
a
 in 
nm.  
 
 
Table 2. Irradiation times (tirr, in hours), rate constants (k, in 10
-2 
h
-1
) and photochemical quantum 
yields (Φphot, × 10
-3
) for the photolysis of conjugates 2a-e at different wavelengths in MeOH/HEPES 
buffer (80:20) and ACN/HEPES buffer (80:20) solution. 
 
Figure 1. Normalised UV/vis absorption and fluorescence spectra of conjugate 2b in MeOH/HEPES 
buffer (80:20) (full line, λexc = 344 nm), and ACN/HEPES buffer (80:20) (spaced line, λexc = 341 nm) 
solutions.  
 
Figure 2. Plot of ln A versus irradiation time for the photolysis of compounds 2a (♦), 2b (■), 2c (▲), 
2d (×) and 2e (●) at 300 nm in ACN/HEPES buffer (80:20) solution.   
